Nov 9, 2023
It would seem sensible to assume that profitable products are less likely to suffer shortages, concessions and price spikes than products where profit is hard to come by. Charles Joynson, WaveData MD, compared the reimbursement price and the average market price for...
Oct 10, 2023
Charles Joynson, WaveData MD, drilled into this to see where the increase is coming from, demonstrating that it’s a mixture of parallel import and generics which are driving the rise. – Parallel imports have risen from £22.73 in Sept 2013 to 26.24 in August...
Sep 20, 2023
Charles Joynson, WaveData MD, puts a spotlight on Lustral Tabs as we explore the product lifecycle post LOE. Before generics were launched in November 2005 there was a high degree of similarity between the price of the UK and PI (parallel import) packs of Lustral Tabs...
Sep 7, 2023
At first we struggled to understand why this product had been added to the list of DHSC Concessions in July. Actually it had the highest concession price at £214.96, but the market price had remained high as had the reimbursement price. However it was only when we...
Aug 24, 2023
Normally we expect branded devices to maintain their pharmacy purchase prices over long periods of time. However, here this is not the case. Charles Joynson, WaveData MD investigates further. Looking at the long term market price trends of Freestyle Optium Test Strips...
Jun 6, 2023
Client X is launching a new generic product into the UK market, they were looking for data to assess market potential, support their forecasting and feed into the commercial strategy. Our Customer Success Manager and Data Team worked closely with the Client’s...
